SCM

Silverarc Capital Management Portfolio holdings

AUM $691M
1-Year Est. Return 359.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+359.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$691M
AUM Growth
+$420K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1
+$23.5M
2
+$19.8M
3
+$14.1M
4
COGT icon
Cogent Biosciences
COGT
+$12.1M
5
PFE icon
Pfizer
PFE
+$10.6M

Top Sells

1
+$36.8M
2
+$30.6M
3
+$24.8M
4
INSM icon
Insmed
INSM
+$24.7M
5
CDTX
Cidara Therapeutics
CDTX
+$21.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
51
Kymera Therapeutics
KYMR
$7.34B
$2.69M 0.39%
+34,589
NXTC icon
52
NextCure
NXTC
$45.5M
$2.5M 0.36%
+176,057
ELUT icon
53
Elutia
ELUT
$48.8M
$1.91M 0.28%
2,751,314
-99,673
SION
54
Sionna Therapeutics
SION
$1.95B
$1.71M 0.25%
41,460
-67,341
CTMX icon
55
CytomX Therapeutics
CTMX
$981M
$1.64M 0.24%
+385,974
XFOR icon
56
X4 Pharmaceuticals
XFOR
$382M
$1.43M 0.21%
+357,387
EWTX icon
57
Edgewise Therapeutics
EWTX
$3.56B
$1.04M 0.15%
+42,052
RADX
58
Radiopharm Theranostics
RADX
$36.3M
$978K 0.14%
187,406
FDMT icon
59
4D Molecular Therapeutics
FDMT
$493M
$750K 0.11%
+100,000
ADGM
60
Adagio Medical Holdings
ADGM
$36.2M
$536K 0.08%
+515,384
RAPP
61
Rapport Therapeutics
RAPP
$1.73B
$293K 0.04%
9,659
-194,287
PALI icon
62
Palisade Bio
PALI
$345M
$240K 0.03%
+102,108
IBIO icon
63
iBio
IBIO
$75.7M
$205K 0.03%
+106,000
RCKTW icon
64
Rocket Pharmaceuticals Warrant
RCKTW
$1.09M
$2.55K ﹤0.01%
104,828
AKRO
65
DELISTED
Akero Therapeutics
AKRO
– –
-643,636
ALKS icon
66
Alkermes
ALKS
$5.63B
– –
-180,513
ARCT icon
67
Arcturus Therapeutics
ARCT
$247M
– –
-3,445
BDSX icon
68
Biodesix
BDSX
$123M
– –
-49,607
CAMP icon
69
CAMP4 Therapeutics
CAMP
$235M
– –
-653,594
CAPR icon
70
Capricor Therapeutics
CAPR
$2.01B
– –
0
CDTX
71
DELISTED
Cidara Therapeutics
CDTX
– –
-220,902
CRNX icon
72
Crinetics Pharmaceuticals
CRNX
$4.16B
– –
-50,000
CYTK icon
73
Cytokinetics
CYTK
$8.17B
– –
-211,000
DCTH icon
74
Delcath Systems
DCTH
$379M
– –
-203,386
DYN icon
75
Dyne Therapeutics
DYN
$3.3B
– –
-100,000
1 2
3
4